Search

Your search keyword '"Mallebranche, Coralie"' showing total 7 results
Start Over Author "Mallebranche, Coralie" Publisher wiley
7 results on '"Mallebranche, Coralie"'

1. Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcome

Author

Pincez, Thomas, primary, Fernandes, Helder, additional, Fahd, Mony, additional, Pasquet, Marlène, additional, Chahla, Wadih Abou, additional, Granel, Jérome, additional, Ducassou, Stéphane, additional, Thomas, Caroline, additional, Garnier, Nathalie, additional, Jeziorski, Eric, additional, Bayart, Sophie, additional, Chastagner, Pascal, additional, Cheikh, Nathalie, additional, Guitton, Corinne, additional, Paillard, Catherine, additional, Lejeune, Julien, additional, Millot, Frédéric, additional, Li‐Thiao Te, Valérie, additional, Mallebranche, Coralie, additional, Pellier, Isabelle, additional, Castelle, Martin, additional, Armari‐Alla, Corinne, additional, Carausu, Liana, additional, Piguet, Christophe, additional, Benadiba, Joy, additional, Pluchart, Claire, additional, Stephan, Jean‐Louis, additional, Deparis, Marianna, additional, Briandet, Claire, additional, Doré, Eric, additional, Marie‐Cardine, Aude, additional, Barlogis, Vincent, additional, Leverger, Guy, additional, Héritier, Sébastien, additional, Aladjidi, Nathalie, additional, and Leblanc, Thierry, additional

Published
2024
Full Text
View/download PDF

2. Impact of age at diagnosis, sex, and immunopathological manifestations in 886 patients with pediatric chronic immune thrombocytopenia

Author

Pincez, Thomas, primary, Fernandes, Helder, additional, Pasquet, Marlène, additional, Abou Chahla, Wadih, additional, Granel, Jérome, additional, Héritier, Sébastien, additional, Fahd, Mony, additional, Ducassou, Stéphane, additional, Thomas, Caroline, additional, Garnier, Nathalie, additional, Barlogis, Vincent, additional, Jeziorski, Eric, additional, Bayart, Sophie, additional, Chastagner, Pascal, additional, Cheikh, Nathalie, additional, Guitton, Corinne, additional, Paillard, Catherine, additional, Lejeune, Julien, additional, Millot, Frédéric, additional, Li‐Thiao Te, Valérie, additional, Mallebranche, Coralie, additional, Pellier, Isabelle, additional, Neven, Bénédicte, additional, Armari‐Alla, Corinne, additional, Carausu, Liana, additional, Piguet, Christophe, additional, Benadiba, Joy, additional, Pluchart, Claire, additional, Stephan, Jean‐Louis, additional, Deparis, Marianna, additional, Briandet, Claire, additional, Doré, Eric, additional, Marie‐Cardine, Aude, additional, Leblanc, Thierry, additional, Leverger, Guy, additional, and Aladjidi, Nathalie, additional

Published
2023
Full Text
View/download PDF

3. The French FRACTURE database: A way to improve knowledge on management of children with very rare tumors

Author

Mallebranche, Coralie, primary, Reguerre, Yves, additional, Fresneau, Brice, additional, Andre, Nicolas, additional, Berger, Claire, additional, Briandet, Claire, additional, Castex, Marie‐Pierre, additional, Defachelles, Anne‐Sophie, additional, Faure‐Conter, Cécile, additional, Lejeune, Julien, additional, Klein, Sébastien, additional, Leverger, Guy, additional, Marie‐Cardine, Aude, additional, Oudot, Caroline, additional, Freycon, Claire, additional, Proust, Stéphanie, additional, Roumy, Marianne, additional, Thebaud, Estelle, additional, Verite, Cécile, additional, Lacour, Brigitte, additional, and Orbach, Daniel, additional

Published
2022
Full Text
View/download PDF

4. Impact of COVID‐19 on cancer care: A survey from the French Society of Pediatric Oncology (SFCE)

Author

Rouger‐Gaudichon, Jérémie, primary, Gariazzo, Luisa, additional, Thébault, Eric, additional, Brethon, Benoît, additional, Fenwarth, Laurène, additional, Gambart, Marion, additional, Alimi, Aurélia, additional, Réguerre, Yves, additional, Piguet, Christophe, additional, Jubert, Charlotte, additional, Gouache, Elodie, additional, Thébaud, Estelle, additional, Plantaz, Dominique, additional, Paillard, Catherine, additional, Raimbault, Sandra, additional, Haouy, Stéphanie, additional, Schneider, Pascale, additional, Phulpin, Aurélie, additional, Mallebranche, Coralie, additional, Dubrasquet, Mathilde, additional, Berranger, Eva, additional, Devoldere, Catherine, additional, Laithier, Véronique, additional, Poirée, Maryline, additional, Thouvenin, Sandrine, additional, Carausu, Liana, additional, Dupraz, Chrystelle, additional, Bouttefroy, Séverine, additional, André, Nicolas, additional, and Gandemer, Virginie, additional

Published
2020
Full Text
View/download PDF

5. Is surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experience

Author

Vaarwerk, Bas, primary, Mallebranche, Coralie, additional, Affinita, Maria C., additional, Lee, Johanna H., additional, Ferrari, Andrea, additional, Chisholm, Julia C., additional, Defachelles, Anne‐Sophie, additional, De Salvo, Gian Luca, additional, Corradini, Nadège, additional, Minard‐Colin, Veronique, additional, Morosi, Carlo, additional, Brisse, Hervé J., additional, McHugh, Kieran, additional, Bisogno, Gianni, additional, Rijn, Rick R., additional, Orbach, Daniel, additional, and Merks, Johannes H. M., additional

Published
2019
Full Text
View/download PDF

6. Rapid haemoglobin A and S quantification using Tosoh HLC-723G8 in variant mode for patients with sickle cell disease.

Author

Fadel J, Noyelle J, Maingon M, Homedan C, Dieu X, de la Barca JMC, Reynier P, Mallebranche C, Brasme JF, Mirebeau-Prunier D, Orvain C, and Chabrun F

Subjects
Humans, Glycated Hemoglobin, Reproducibility of Results, Hemoglobin A, Anemia, Sickle Cell, Hemoglobin, Sickle
Abstract

The management of life-threatening complications in patients with sickle cell disease (SCD) requires an accurate and reproducible quantification of haemoglobin A (HbA) and S (HbS) with a short turnaround time and 24-7 availability. We propose a novel method for quantifying HbA and HbS using the glycated haemoglobin (HbA1c) assay on a Tosoh HLC-723G8 (G8) analyser in variant mode. HbA and HbS results obtained using our method highly correlated with results obtained using a reference method (r > 0.99 for 124 samples of patients with SCD or sickle cell trait). Our method met laboratory requirements for linearity (coefficient of variation [CV] and bias <5%), between-run and within-run reproducibility (CV <10%) and carryover (<0.5%) over the range of HbS and HbA values expected in a therapeutic context. Using the G8 analyser in variant mode is viable for monitoring HbA and HbS concentrations in dire situations. This method is easy to use, quick (1.6 min per sample), and automatable and produces highly reproducible results without significant bias. Finally, it does not require modifications to the analytical pipeline recommended by the supplier, enabling a 24-7 availability without disrupting routine monitoring of HbA1c in the laboratory., (© 2023 John Wiley & Sons, Ltd.)

Published
2024
Full Text
View/download PDF

7. Is surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experience.

Author

Vaarwerk B, Mallebranche C, Affinita MC, van der Lee JH, Ferrari A, Chisholm JC, Defachelles AS, De Salvo GL, Corradini N, Minard-Colin V, Morosi C, Brisse HJ, McHugh K, Bisogno G, van Rijn RR, Orbach D, and Merks JHM

Subjects
Child, Child, Preschool, Diagnostic Imaging statistics & numerical data, Disease-Free Survival, Female, Follow-Up Studies, France, Humans, Italy, Magnetic Resonance Imaging methods, Magnetic Resonance Imaging statistics & numerical data, Male, Monitoring, Physiologic statistics & numerical data, Neoplasm Recurrence, Local, Netherlands, Retrospective Studies, Rhabdomyosarcoma pathology, Tomography, X-Ray Computed methods, Tomography, X-Ray Computed statistics & numerical data, United Kingdom, Diagnostic Imaging methods, Monitoring, Physiologic methods, Rhabdomyosarcoma diagnostic imaging, Rhabdomyosarcoma therapy
Abstract

Background: After the completion of therapy, patients with localized rhabdomyosarcoma (RMS) are subjected to intensive radiological tumor surveillance. However, the clinical benefit of this surveillance is unclear. This study retrospectively analyzed the value of off-therapy surveillance by comparing the survival of patients in whom relapse was detected by routine imaging (the imaging group) and patients in whom relapse was first suspected by symptoms (the symptom group)., Methods: This study included patients with relapsed RMS after the completion of therapy for localized RMS who were treated in large pediatric oncology hospitals in France, the United Kingdom, Italy, and the Netherlands and who were enrolled in the International Society of Paediatric Oncology Malignant Mesenchymal Tumor 95 (1995-2004) study, the Italian Paediatric Soft Tissue Sarcoma Committee Rhabdomyosarcoma 96 (1996-2004) study, or the European Paediatric Soft Tissue Sarcoma Study Group Rhabdomyosarcoma 2005 (2005-2013) study. The survival times after relapse were compared with a log-rank test between patients in the imaging group and patients in the symptom group., Results: In total, 199 patients with relapsed RMS were included: 78 patients (39.2%) in the imaging group and 121 patients (60.8%) in the symptom group. The median follow-up time after relapse was 7.4 years (interquartile range, 3.9-11.5 years) for survivors (n = 86); the 3-year postrelapse survival rate was 50% (95% confidence interval [CI], 38%-61%) for the imaging group and 46% (95% CI, 37%-55%) for the symptom group (P = .7)., Conclusions: Although systematic routine imaging is the standard of care after RMS therapy, the majority of relapses were detected as a result of clinical symptoms. This study found no survival advantage for patients whose relapse was detected before the emergence of clinical symptoms. These results show that the value of off-therapy surveillance is controversial, particularly because repeated imaging may also entail potential harm., (© 2019 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society.)

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results